Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1896 1
1946 2
1947 2
1951 2
1952 3
1953 7
1954 8
1955 8
1956 9
1957 4
1958 5
1959 8
1960 6
1961 7
1962 5
1963 5
1964 1
1965 9
1966 13
1967 36
1968 53
1969 39
1970 51
1971 57
1972 56
1973 50
1974 70
1975 51
1976 82
1977 59
1978 67
1979 79
1980 70
1981 80
1982 102
1983 92
1984 112
1985 115
1986 125
1987 115
1988 109
1989 132
1990 134
1991 138
1992 130
1993 121
1994 142
1995 121
1996 134
1997 117
1998 123
1999 133
2000 128
2001 95
2002 136
2003 111
2004 102
2005 104
2006 137
2007 140
2008 139
2009 144
2010 148
2011 128
2012 144
2013 120
2014 140
2015 153
2016 135
2017 139
2018 148
2019 131
2020 118
2021 137
2022 144
2023 115
2024 136
2025 174
2026 73

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,311 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean raynauds phenomenon pathogenesis (6,245 results)?
Raynaud's phenomenon.
Herrick AL, Wigley FM. Herrick AL, et al. Best Pract Res Clin Rheumatol. 2020 Feb;34(1):101474. doi: 10.1016/j.berh.2019.101474. Epub 2020 Jan 29. Best Pract Res Clin Rheumatol. 2020. PMID: 32007400 Review.
Raynaud's phenomenon (RP) is common, affecting approximately 5% of the population, and is important to the rheumatologist because it is often the presenting symptom of connective tissue disease, especially of systemic sclerosis (SSc)-spectrum disorders. ...Ho …
Raynaud's phenomenon (RP) is common, affecting approximately 5% of the population, and is important to the rheumatologist beca …
Raynaud's Phenomenon.
Wigley FM, Flavahan NA. Wigley FM, et al. N Engl J Med. 2016 Aug 11;375(6):556-65. doi: 10.1056/NEJMra1507638. N Engl J Med. 2016. PMID: 27509103 Review. No abstract available.
Raynaud's phenomenon.
Haque A, Hughes M. Haque A, et al. Clin Med (Lond). 2020 Nov;20(6):580-587. doi: 10.7861/clinmed.2020-0754. Clin Med (Lond). 2020. PMID: 33199324 Free PMC article.
Raynaud's phenomenon (RP) is a common vasospastic condition which affects ~5% of the general population. The majority of individuals have primary RP; however, Raynaud's can also occur secondary to a broad range of underlying medical conditions and drug therap …
Raynaud's phenomenon (RP) is a common vasospastic condition which affects ~5% of the general population. The majority of indiv …
Pathogenesis of Raynaud's phenomenon.
Herrick AL. Herrick AL. Rheumatology (Oxford). 2005 May;44(5):587-96. doi: 10.1093/rheumatology/keh552. Epub 2005 Mar 1. Rheumatology (Oxford). 2005. PMID: 15741200 Review.
A key point is that Raynaud's phenomenon can be either primary (idiopathic) or secondary to a number of underlying conditions, and that the pathogenesis and pathophysiology vary between these conditions. This review concentrates upon those subtypes of Rayn …
A key point is that Raynaud's phenomenon can be either primary (idiopathic) or secondary to a number of underlying conditions, …
Raynaud's phenomenon-an update on diagnosis, classification and management.
Pauling JD, Hughes M, Pope JE. Pauling JD, et al. Clin Rheumatol. 2019 Dec;38(12):3317-3330. doi: 10.1007/s10067-019-04745-5. Epub 2019 Aug 16. Clin Rheumatol. 2019. PMID: 31420815 Review.
Raynaud's phenomenon (RP) is used to describe a symptom complex caused by digital vascular compromise. ...Raynaud's phenomenon causes significant disease-related morbidity in autoimmune rheumatic diseases such as systemic sclerosis....
Raynaud's phenomenon (RP) is used to describe a symptom complex caused by digital vascular compromise. ...Raynaud's …
Raynaud's phenomenon: pathogenesis and management.
Bakst R, Merola JF, Franks AG Jr, Sanchez M. Bakst R, et al. J Am Acad Dermatol. 2008 Oct;59(4):633-53. doi: 10.1016/j.jaad.2008.06.004. Epub 2008 Jul 24. J Am Acad Dermatol. 2008. PMID: 18656283 Review.
Raynaud's phenomenon is a common clinical disorder for which patients frequently seek the expertise and care of dermatologists. ...Recently, there has been renewed interest in finding the pathogenetic mechanisms of Raynaud's phenomenon, an effort that …
Raynaud's phenomenon is a common clinical disorder for which patients frequently seek the expertise and care of dermatologists …
Raynaud's phenomenon.
Devgire V, Hughes M. Devgire V, et al. Br J Hosp Med (Lond). 2019 Nov 2;80(11):658-664. doi: 10.12968/hmed.2019.80.11.658. Br J Hosp Med (Lond). 2019. PMID: 31707892 Review.
Therefore, hospital-based specialists are frequently involved in the care of patients with Raynaud's phenomenon and need to be aware of associated conditions and prescribed medications for Raynaud's phenomenon. In particular, Raynaud's phenom …
Therefore, hospital-based specialists are frequently involved in the care of patients with Raynaud's phenomenon and need to be …
Raynaud's phenomenon: from molecular pathogenesis to therapy.
Prete M, Fatone MC, Favoino E, Perosa F. Prete M, et al. Autoimmun Rev. 2014 Jun;13(6):655-67. doi: 10.1016/j.autrev.2013.12.001. Epub 2014 Jan 10. Autoimmun Rev. 2014. PMID: 24418302 Review.
Raynaud's phenomenon (RP) is a well defined clinical syndrome characterized by recurrent episodes of digital vasospasm triggered by exposure to physical/chemical or emotional stress. ...The pathogenesis of RP has not yet been entirely clarified, nor is it kno …
Raynaud's phenomenon (RP) is a well defined clinical syndrome characterized by recurrent episodes of digital vasospasm trigger …
Raynaud's phenomenon.
Gayraud M. Gayraud M. Joint Bone Spine. 2007 Jan;74(1):e1-8. doi: 10.1016/j.jbspin.2006.07.002. Epub 2006 Dec 4. Joint Bone Spine. 2007. PMID: 17218139 Review.
They are associated with connective tissue disease; for example, 90% of patients with scleroderma experience Raynaud's phenomenon. ...These drugs were developed as a result of new knowledge on the pathogenesis of Raynaud's phenomenon. Acr …
They are associated with connective tissue disease; for example, 90% of patients with scleroderma experience Raynaud's phen …
Raynaud's phenomenon.
Hughes M, Herrick AL. Hughes M, et al. Best Pract Res Clin Rheumatol. 2016 Feb;30(1):112-32. doi: 10.1016/j.berh.2016.04.001. Epub 2016 May 11. Best Pract Res Clin Rheumatol. 2016. PMID: 27421220 Free article. Review.
Raynaud's phenomenon (RP) is a major cause of pain and disability in patients with autoimmune connective tissue diseases (CTDs), particularly systemic sclerosis (SSc). ...Future research is required to increase the understanding of the pathogenesis and natura …
Raynaud's phenomenon (RP) is a major cause of pain and disability in patients with autoimmune connective tissue diseases (CTDs …
6,311 results